CHT101 Clinical Trials
2 recruitingBiologic
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies
Tianjin Medical University Cancer Institute and Hospital24 enrolled1 locationNCT06914037
Recruiting
Phase 1
A Clinical Study of CHT101 in CD70-Positive Advanced Solid Tumors
Relapsed / Refractory Solid Tumor
Tianjin Medical University Cancer Institute and Hospital36 enrolled1 locationNCT06730659